BGN has been shown to regulate various signaling pathways in tissue specific cancers such as p38 signaling in colon cancer [16], NFκB signaling in gastric cancer [23] and PI3K-Akt-NFκB signaling axis in retinoblastomas [24]. This evidence concerns the gene NFKB1 and gastric cancer.